| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/27/1992 | CA2061406A1 Immunosuppressive drug |
| 08/27/1992 | CA2061405A1 Immunopotentiating drug |
| 08/27/1992 | CA2059824A1 Hybridomas and monoclonal antibodies that inhibit anti-cd3-stimulated t cell proliferation |
| 08/26/1992 | EP0500360A1 Quinoline-containing ketoacids as leukotriene antagonists |
| 08/26/1992 | EP0500205A1 Benzodioxole derivatives |
| 08/26/1992 | EP0499926A1 2-Substituted quinolines, process for their preparation as well as their use in medicaments |
| 08/26/1992 | EP0499662A1 Compositions with enhanced penetration |
| 08/26/1992 | EP0265508B1 Production and use of reaction product obtained from ascorbic acid with alpha,beta-unsaturated alicyclic ketone or vinyl aliphatic ketone |
| 08/26/1992 | EP0246322B1 Treatment of aids-type disease |
| 08/25/1992 | US5142056 Human immunodeficiency virus protease inhibitor |
| 08/25/1992 | US5141952 Heterocyclic dicarboxylic acids |
| 08/25/1992 | US5141950 Benzimidazole compounds and their use |
| 08/25/1992 | US5141743 Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same |
| 08/25/1992 | CA1306746C Cyclic amino-thioacetal amides, a process for the preparation thereofand pharmaceutical compositions containing them |
| 08/25/1992 | CA1306744C Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
| 08/20/1992 | WO1992014150A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | WO1992013950A2 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 08/20/1992 | WO1992013949A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 08/20/1992 | WO1992013873A1 Novel steroid esters |
| 08/20/1992 | WO1992013872A1 Novel steroids |
| 08/20/1992 | WO1992013568A1 Vp6 encapsulated drug delivery |
| 08/20/1992 | WO1992013561A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 08/20/1992 | WO1992013546A1 Mb-40 peptide that enhances the production of interleukin-1 and modulates age-associated immune response |
| 08/20/1992 | WO1992013536A1 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 08/20/1992 | CA2103924A1 Novel steroids |
| 08/20/1992 | CA2103893A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | CA2101735A1 Vp6 encapsulated drug delivery |
| 08/20/1992 | CA2100453A1 Novel steroid esters |
| 08/19/1992 | EP0499544A2 Use of tetrahydropiridin-derivatives as inhibitors of angiogenesis |
| 08/19/1992 | EP0499521A1 Inhibitors of N-myristoyltransferase, their preparation process and pharmaceutical compositions containing them |
| 08/19/1992 | EP0499467A2 Use of quinones in the treatment of cancer or AIDS |
| 08/19/1992 | EP0499313A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 08/19/1992 | EP0499161A2 GM-CSF inhibiting antibodies |
| 08/19/1992 | EP0499112A1 Antibodies against an IgE receptor |
| 08/19/1992 | CN1063685A Calcium uptake inhibitors |
| 08/18/1992 | CA1306461C Benzhydryloxyethylpiperazine derivatives, processes for their preparation and pharmaceutical compositions in which they are present |
| 08/15/1992 | CA2061173A1 Compositions comprising tetrahydrothienopyridine derivatives as angiogenesis inhibitors |
| 08/14/1992 | WO1992014734A1 Imidazopyridine paf/h1 antagonists |
| 08/14/1992 | WO1992014454A1 Use of quinones in the treatment of cancer or aids |
| 08/14/1992 | CA2104009A1 Use of quinones in the treatment of cancer or aids |
| 08/12/1992 | EP0498770A1 Certain benzodioxole, benzodioxane and benzodioxepin derivatives |
| 08/12/1992 | EP0498767A2 Chimeric antiidiotypic monoclonal antibodies |
| 08/12/1992 | EP0498718A1 Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydro-pyridine-derivatives as free radical scavengers |
| 08/12/1992 | EP0498658A2 Composition for inducing humoral anergy to an immunogen |
| 08/12/1992 | EP0498334A1 2,4- and 2,5-bis-(tetrazolyl)pyridines, process for their preparation and their use as medicines |
| 08/12/1992 | EP0497904A1 Compositions containing plant-produced glycopolypeptide multimers and methods for their production |
| 08/12/1992 | EP0497888A1 Substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid derivatives as inhibitors of pla 2? and lipoxygenase |
| 08/12/1992 | EP0497883A1 Compositions and their use for promoting immunopotentiation |
| 08/12/1992 | EP0497867A1 Polypeptide inhibitors of gamma interferon |
| 08/12/1992 | CN1063416A Avirulent microbes and uses therefor:salmonella typhi |
| 08/12/1992 | CA2060967A1 N-myristoyltransferase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 08/12/1992 | CA2060949A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 08/12/1992 | CA2060741A1 Gm-csf inhibiting oligopeptides |
| 08/12/1992 | CA2059842A1 Ige-receptor-antibodies |
| 08/11/1992 | US5137917 Immunopotentiators; administering to mammals |
| 08/11/1992 | US5137913 Diaryl ether cyclic ethers |
| 08/11/1992 | US5137897 Nonsteroidal antiinflammatory agents; therapy for rheumatic diseases |
| 08/11/1992 | US5137876 Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same |
| 08/11/1992 | CA1306255C Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives |
| 08/09/1992 | WO1992013558A1 A composition for inducing humoral anergy |
| 08/09/1992 | CA2060788A1 Certain benzodioxole, benzodioxane and benzodioxepin derivatives |
| 08/08/1992 | WO1992013848A1 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives |
| 08/08/1992 | CA2101539A1 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives |
| 08/07/1992 | CA2060626A1 Chimeric antiidiotypic monoclonal antibodies |
| 08/06/1992 | WO1992013095A1 Methods for treating tumor necrosis factor mediated diseases |
| 08/06/1992 | WO1992012996A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | CA2101065A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | CA2060622A1 2,4- and 2,5-bistetrazolylpyridines, a process for the preparation thereof and the use thereof as pharmaceuticals |
| 08/05/1992 | WO1992013865A1 Pmn-derived cr3 modulator and uses thereof |
| 08/05/1992 | EP0497609A1 Pyrimido-benzothiazine derivatives for the treatment of inflammation, allergy and cardiovascular disease |
| 08/05/1992 | EP0497515A1 New process for producing FK-506 |
| 08/05/1992 | EP0261185B1 7-oxoprostacycline derivatives and process for their manufacture |
| 08/05/1992 | CN1017707B Process for preparation of new thiazole compounds |
| 08/05/1992 | CA2103923A1 Pmn-derived cr3 modulator and uses thereof |
| 08/04/1992 | US5135952 Antiinflammatory and/or antiallergic methods |
| 08/04/1992 | US5135938 Leukotriene antagonists |
| 08/04/1992 | US5135934 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents |
| 08/04/1992 | CA1305928C Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 08/02/1992 | WO1992013569A1 Targeted polymeric conjugates of cyclosporin and method for their preparation |
| 08/02/1992 | CA2079590A1 Targeted polymeric conjugates of cyclosporin and method for their preparation |
| 07/30/1992 | CA2035143A1 Compositions with enhanced penetration |
| 07/29/1992 | EP0496691A1 Diphenylmethylpiperazine derivatives |
| 07/29/1992 | EP0496579A2 Modified immunogens comprising an immunogen attached to one or more non-immunogenic polymers |
| 07/29/1992 | EP0496306A1 Process for the preparation of 3-amino-9,13b-dihydro-1H-dibenz-[c,f]imidazo[1,5-a]azepine hydrochloride |
| 07/29/1992 | EP0496160A1 Synthetic conversion of bryostatin 2 into bryostatin 1 |
| 07/29/1992 | EP0496013A1 Synthetic peptide derived from human lipocortin V and use thereof |
| 07/29/1992 | EP0495919A1 PROTECTION FROM SHOCK SUBSEQUENT TO INJURY BY DOUBLE-STRANDED RNAs. |
| 07/29/1992 | EP0346501B1 Pharmaceutical preparation for treating immunodeficiency conditions |
| 07/29/1992 | CN1063100A Heterocyclic compounds |
| 07/29/1992 | CN1017626B Growth resulating factor for new cell |
| 07/29/1992 | CA2059706A1 Microoganism for producing fk-506 |
| 07/28/1992 | US5134159 Skin disorders |
| 07/28/1992 | US5134151 Platelet Activating Factor Antagonist |
| 07/28/1992 | CA1305827C Spergualin-related compounds and process for producing the same |
| 07/24/1992 | CA2058464A1 Induction of tolerance with modified immunogens |
| 07/23/1992 | WO1992012119A1 The effect of n,n,n-trimethylsphingosine on protein kinase-c activity; melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation |
| 07/23/1992 | WO1992011847A1 A method of inhibiting endotoxin induced effects |
| 07/23/1992 | WO1992011846A1 Particulates |
| 07/23/1992 | CA2097324A1 Effect of n,n,n-trimethylsphingosine on protein kinase-c activity; melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation |
| 07/22/1992 | EP0495594A1 Sulphonamide derivatives |